Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Narrow QRS complex tachycardias

S J Pieper1, M S Stanton

  • 1Division of Cardiovascular Diseases, Mayo Clinic Rochester, MN 55905.

Mayo Clinic Proceedings
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atrial therapies reduce atrial arrhythmia burden in defibrillator patients.

Circulation·2001
Same author

Is sinus node modification appropriate for inappropriate sinus tachycardia with features of postural orthostatic tachycardia syndrome?

Pacing and clinical electrophysiology : PACE·2001
Same author

Prospective postmarket device studies versus returned product analysis as a predictor of system survival.

Pacing and clinical electrophysiology : PACE·2000
Same author

Defibrillator challenges for the new millennium: the marriage of device and patient-making and maintaining a good match.

Journal of cardiovascular electrophysiology·2000
Same author

Factors affecting the frequency of subcutaneous lead usage in implantable defibrillators.

Pacing and clinical electrophysiology : PACE·2000
Same author

Global right atrial mapping of human atrial flutter: the presence of posteromedial (sinus venosa region) functional block and double potentials : a study in biplane fluoroscopy and intracardiac echocardiography.

Circulation·2000
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
Same journal

Chronic Kidney Disease-In the Limelight, July 2026.

Mayo Clinic proceedings·2026
Same journal

In Reply: Long-Term Cardiovascular Burden After Carotid Endarterectomy: Moving Beyond Conventional Risk Profiling.

Mayo Clinic proceedings·2026
Same journal

Long-Term Cardiovascular Burden After Carotid Endarterectomy: Moving Beyond Conventional Risk Profiling.

Mayo Clinic proceedings·2026
Same journal

Real-World Comparative Effectiveness of Tirzepatide and Semaglutide for Obesity: A Multicentered Study.

Mayo Clinic proceedings·2026
See all related articles

Diagnosing narrow QRS complex tachycardias involves identifying P waves to classify them as long RP or short RP. Intravenous adenosine is the preferred treatment for most supraventricular tachycardias due to its high efficacy and safety.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Internal Medicine

Background:

  • Narrow QRS complex tachycardias are frequently encountered in primary care settings.
  • While often benign, these arrhythmias can cause significant patient symptoms.
  • Effective diagnosis and management are crucial for patient care.

Purpose of the Study:

  • To outline a diagnostic approach for regular narrow QRS complex tachycardias.
  • To emphasize the importance of identifying atrial activity (P waves).
  • To highlight the role of adenosine in managing these tachycardias.

Main Methods:

  • Surface electrocardiogram (ECG) analysis to identify P waves.
  • Classification of tachycardias based on RP interval (long RP vs. short RP).

Related Experiment Videos

  • Utilizing adenosine for acute termination of supraventricular tachycardias.
  • Main Results:

    • Identifying P waves and classifying RP intervals aids in differential diagnosis.
    • Adenosine effectively terminates approximately 90% of supraventricular tachycardia episodes.
    • Adenosine demonstrates a favorable safety profile with minimal side effects.

    Conclusions:

    • A systematic approach to narrow QRS complex tachycardias improves diagnosis and management.
    • Classification based on P wave identification and RP interval is key.
    • Intravenous adenosine is the drug of choice for terminating most narrow QRS complex tachycardias.